OS Therapies (NYSE:OSTX) Earns Buy Rating from D. Boral Capital
D. Boral Capital restated their buy rating on shares of OS Therapies (NYSE:OSTX – Free Report) in a research report sent to investors on Monday,Benzinga reports. The brokerage currently has a $20.00 price objective on the stock. Separately, Lake Street Capital started coverage on shares of OS Therapies in a report on Wednesday, April 2nd. […]
D. Boral Capital restated their buy rating on shares of OS Therapies (NYSE:OSTX – Free Report) in a research report sent to investors on Monday,Benzinga reports. The brokerage currently has a $20.00 price objective on the stock. Separately, Lake Street Capital started coverage on shares of OS Therapies in a report on Wednesday, April 2nd. […]
